Literature DB >> 18598143

Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities.

Michelle Le Brocq1, Stephen J Leslie, Philip Milliken, Ian L Megson.   

Abstract

Endothelial dysfunction has been implicated as a key factor in the development of a wide range of cardiovascular diseases, but its definition and mechanisms vary greatly between different disease processes. This review combines evidence from cell-culture experiments, in vitro and in vivo animal models, and clinical studies to identify the variety of mechanisms involved in endothelial dysfunction in its broadest sense. Several prominent disease states, including hypertension, heart failure, and atherosclerosis, are used to illustrate the different manifestations of endothelial dysfunction and to establish its clinical implications in the context of the range of mechanisms involved in its development. The size of the literature relating to this subject precludes a comprehensive survey; this review aims to cover the key elements of endothelial dysfunction in cardiovascular disease and to highlight the importance of the process across many different conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18598143     DOI: 10.1089/ars.2007.2013

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  67 in total

Review 1.  Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).

Authors:  Shehzad Sami; James T Willerson
Journal:  Tex Heart Inst J       Date:  2010

2.  Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome.

Authors:  Phillip C Delekta; Ingrid J Apel; Shufang Gu; Katy Siu; Yoshiyuki Hattori; Linda M McAllister-Lucas; Peter C Lucas
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 3.  Hug tightly and say goodbye: role of endothelial ICAM-1 in leukocyte transmigration.

Authors:  Arshad Rahman; Fabeha Fazal
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

Review 4.  Inorganic nitrite supplementation for healthy arterial aging.

Authors:  Amy L Sindler; Allison E Devan; Bradley S Fleenor; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2014-01-09

5.  A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.

Authors:  Qingzhi Zhang; Agnieszka Kulczynska; David J Webb; Ian L Megson; Nigel P Botting
Journal:  Chem Commun (Camb)       Date:  2013-02-18       Impact factor: 6.222

6.  Attenuation of angiotensin II-induced hypertension and cardiac hypertrophy in transgenic mice overexpressing a type 1 receptor mutant.

Authors:  Saad Ahmad; Francesca Cesana; Edward Lamperti; Haralambos Gavras; Jun Yu
Journal:  Am J Hypertens       Date:  2009-09-24       Impact factor: 2.689

Review 7.  THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.

Authors:  Anna Grodzinsky; Suzanne V Arnold; Dany Jacob; Boris Draznin; Mikhail Kosiborod
Journal:  Endocr Pract       Date:  2016-12-14       Impact factor: 3.443

8.  A genetic study of the NOS3 gene for ischemic stroke in a Chinese population.

Authors:  Danhua Du; Peng Gao; Linsen Hu; Yumei Yang; Feng Wang; Lin Ye; Xuan Zhang; Ming Chang; Jiexu Zhao; Jiang Wu; Ian L Megson; Jun Wei
Journal:  Int J Gen Med       Date:  2008-11-30

Review 9.  Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine.

Authors:  David Feldman; Terry S Elton; Doron M Menachemi; Randy K Wexler
Journal:  Vasc Health Risk Manag       Date:  2010-06-01

10.  Acute ingestion of a novel whey-derived peptide improves vascular endothelial responses in healthy individuals: a randomized, placebo controlled trial.

Authors:  Kevin D Ballard; Richard S Bruno; Richard L Seip; Erin E Quann; Brittanie M Volk; Daniel J Freidenreich; Diana M Kawiecki; Brian R Kupchak; Min-Yu Chung; William J Kraemer; Jeff S Volek
Journal:  Nutr J       Date:  2009-07-22       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.